In December 2024, NICE recommended the use of tirzepatide (Mounjaro), alongside semaglutide (Wegovy) and liraglutide (Saxenda), for the treatment of weight-related comorbidities.10 NICE recommended these drugs alongside diet and exercise, yet many patients lack structured programs offering nutritional, behavioural, and psychological support
This is the shift I want to examine
Semaglutide, by contrast, binds GLP-1 receptors in the brain and gut to reduce hunger signals, lower blood sugar, and promote satiety
10.3390/molecules191119066 10 ChangC
This product uses acid-resistant capsules that do not dissolve easily in the stomach and are designed to ensure that the ingredients are efficiently absorbed by the body
Side effects become more common at this dose